22 research outputs found
Effectiveness of Angiotensin-Converting Enzyme Inhibitors in Pediatric Patients with Mid to Severe Aortic Valve Regurgitation
The long-term benefit of angiotensin-converting enzyme inhibitors in pediatric patients with aortic valve regurgitation is under consideration. Eighteen patients with mid to severe aortic valve regurgitation were retrospectively evaluated. Echocardiographic parameters (left ventricular end-diastolic diameter, shortening fraction, left ventricular posterior wall thickness, and grade of aortic valve regurgitation) were analyzed before and during therapy with angiotensin-converting enzyme inhibitors. Data are given as standard deviation scores (Z-scores) derived from body surface-adjusted normal values. Median (interquartile range) age at start of therapy was 8.4 (5.4 to 10.0) years, and total follow-up 2.3 (0.9 to 5.4) years. Left ventricular end-diastolic diameter increased from 3.6 (2.3 to 4.5) to 3.7 (2.4 to 4.8), and left ventricular posterior wall diameter decreased from 1.9 (1.1 to 3.0) to 1.1 (0.5 to 2.3). Grade of aortic valve regurgitation increased from 3.5 (2.3 to 4.0) to 4.0 (2.0 to 4.0), and shortening fraction decreased from 39% (34% to 43%) to 37% (34% to 42%). No significant effect of angiotensin-converting enzyme inhibitors on left ventricular dimensions or function was found in our population of patients with mid to severe aortic valve regurgitation. Angiotensin-converting enzyme inhibitors may not alter left ventricular overload in pediatric patients with aortic valve regurgitatio
X-ray Bright Active Galactic Nuclei in Massive Galaxy Clusters I: Number Counts and Spatial Distribution
We present an analysis of the X-ray bright point source population in 43
massive clusters of galaxies observed with the Chandra X-ray Observatory. We
have constructed a catalog of 4210 rigorously selected X-ray point sources in
these fields, which span a survey area of 4.2 square degrees. This catalog
reveals a clear excess of sources when compared to deep blank-field surveys,
which amounts to roughly 1 additional source per cluster, likely Active
Galactic Nuclei (AGN) associated with the clusters. The excess sources are
concentrated within the virial radii of the clusters, with the largest excess
observed near the cluster centers. The average radial profile of the excess
X-ray sources of the cluster are well described by a power law (N(r) ~ r^\beta)
with an index of \beta ~ -0.5. An initial analysis using literature results on
the mean profile of member galaxies in massive X-ray selected clusters
indicates that the fraction of galaxies hosting X-ray AGN rises with increasing
clustercentric radius, being approximately 5 to 10 times higher near the virial
radius than in the central regions. This trend is qualitatively similar to that
observed for star formation in cluster member galaxies.Comment: 18 Pages, 10 Figures, Submitted to MNRAS. Please contact Steven
Ehlert ([email protected]) for higher resolution figures. Updated to
reflect small changes requested by referee. This version has been accepted
into MNRA
Valve-in-valve: Estimating the risk of ostium obstruction in failed sorin stentless valves
Mechanical versus biological aortic valve replacement strategies.
Aortic valve replacement (AVR) is the most frequently performed procedure in valve surgery. The controversy about the optimal choice of the prosthetic valve is as old as the technique itself. Currently there is no perfect valve substitute available. The main challenge is to choose between mechanical and biological prosthetic valves. Biological valves include pericardial (bovine, porcine or equine) and native porcine bioprostheses designed in stented or stentless versions. Homografts and pulmonary autografts are reserved for special indications and will not be discussed in detail in this review. We will focus on the decision making between artificial biological and mechanical prostheses, respectively. The first part of this article reviews guideline recommendations concerning the choice of aortic prostheses in different clinical situations while the second part is focused on novel strategies in the treatment of patients with aortic valve pathology
Posture dependent dynamic external outflow graft compression in HeartMate 3TM left ventricular assist device.
From minimal invasive extracorporeal circulation type I to type III: the perfusionist's view.
Cytokine Removal in Critically Ill Patients Requiring Surgical Therapy for Infective Endocarditis (RECReATE): An Investigator-initiated Prospective Randomized Controlled Clinical Trial Comparing Two Established Clinical Protocols.
INTRODUCTION
Infective endocarditis (IE) and other severe infections induce significant changes in the immune response in a considerable number of affected patients. Numerous IE patients develop a persistent functional immunological phenotype that can best be characterized by a profound anti-inflammation and/ or functional "anergy." This is pronounced in patients with unresolved infectious foci and was previously referred to as "injury-associated immunosuppression" (IAI). IAI can be assessed by measurement of the monocytic human leukocyte antigen-DR (mHLA-DR) expression, a global functional marker of immune competence. Persistence of IAI is associated with prolonged intensive care unit length of stay, increased secondary infection rates, and death. Immunomodulation to reverse IAI was shown beneficial in early immunostimulatory (randomized controlled) clinical trials.
METHODS
Prospective 1:1 randomized controlled clinical study to compare the course of mHLA-DR in patients scheduled for cardiac surgery for IE. Patients will receive either best standard of care plus cytokine adsorption during surgery while on cardiopulmonary bypass (protocol A) versus best standard of care alone, that is, surgery without cytokine adsorption (protocol B). A total of 54 patients will be recruited and randomized. The primary endpoint is a change in quantitative expression of mHLA-DR (antibodies per cell on CD14+ monocytes/ macrophages, assessed using a quantitative standardized assay) from baseline (preoperation [pre-OP], visit 1) to day 1 post-OP (visit 4).
DISCUSSION
This randomized controlled clinical trial (RECReATE) will compare 2 clinical treatment protocols and will investigate whether cytokine adsorption restores monocytic immune competence (reflected by increased mHLA-DR expression) in patients with IE undergoing cardiac surgery.
TRIAL REGISTRATION
This protocol was registered in ClinicalTrials.gov, under number NCT03892174, first listed on March 27, 2019